Dutch scientists find clue explaining brain resistance to Alzheimer’s disease

Scientists in the Netherlands have identified a surprising clue that may explain why some elderly people keep their minds sharp even when their brains show the hallmarks of Alzheimer’s disease. The discovery, published this week, focuses on a small population of immature brain cells that persist well into old age. Researchers found that these cells are still present in individuals over 80, but they act very differently in people who develop dementia compared to those who remain cognitively healthy.

The finding comes at a time when the global burden of Alzheimer’s is soaring and researchers are scrambling for new angles beyond the traditional focus on amyloid plaques and tau tangles. While most studies have examined why plaques form, this work looks at why some brains appear to resist the damage. The Dutch team, led by neuroscientists at the University of Amsterdam, examined post‑mortem brain tissue from more than 200 donors. They discovered that the immature cells, known as “young neurons,” survive much longer than previously thought. In brains of people who never showed cognitive decline, these cells maintained normal patterns of electrical activity and communication. In contrast, in brains of those who suffered dementia, the same cells showed reduced signaling and signs of premature aging.

The researchers say the difference could point to a protective mechanism that keeps neural networks functional despite the presence of disease‑related proteins. “If we can understand how these young neurons stay resilient, we might be able to boost that capacity in everyone,” said lead author Dr. Anika Vermeer. The team plans to test whether drugs that stimulate the growth or activity of these cells can slow cognitive decline in animal models. If successful, the approach could open a new therapeutic pathway that complements existing treatments aimed at clearing plaques. For now, the study adds a fresh piece to the puzzle of why some brains defy Alzheimer’s, offering hope that future interventions may one day preserve memory for more people.